Table 4.
Multivariate analysis for overall mortality.
| NSTEMI | Adjusted OR | 95% CI | P-value | |||
|---|---|---|---|---|---|---|
| Lower | Upper | |||||
| Age | 1.025 | 1.018 | 1.032 | < 0.001 | ||
| CKD | 1.287 | 1.092 | 1.517 | 0.003 | ||
| DM | 1.205 | 1.034 | 1.404 | 0.017 | ||
| HTN | 1.307 | 1.134 | 1.505 | < 0.001 | ||
| Cerebrovascular disease | 1.303 | 1.042 | 1.629 | 0.020 | ||
| Atiral fibrillation | 1.337 | 1.031 | 1.733 | 0.028 | ||
| Smoking | 1.176 | 1.005 | 1.375 | 0.043 | ||
| Use of beta blocker | 0.655 | 0.554 | 0.774 | < 0.001 | ||
| Use of ACE inhibitor/ARB | 0.715 | 0.611 | 0.838 | < 0.001 | ||
| Use of Statin | 0.348 | 0.286 | 0.424 | < 0.001 | ||
| Hb | 0.941 | 0.906 | 0.977 | 0.002 | ||
| proBNP | 1.000 | 1.000 | 1.000 | 0.005 | ||
| hsCRP | 1.023 | 1.004 | 1.042 | 0.019 | ||
| LVEF | 0.990 | 0.984 | 0.996 | 0.001 | ||
| Killip classification | ||||||
| Killip 2 vs 1 | 1.186 | 0.954 | 1.475 | 0.124 | 0.0011 | |
| Killip 3 vs 1 | 1.280 | 1.025 | 1.599 | 0.029 | ||
| Killip 4 vs 1 | 1.562 | 1.227 | 1.989 | < 0.001 | ||
| Target vessel | ||||||
| LCx vs LAD | 0.769 | 0.632 | 0.937 | 0.009 | < 0.001 | |
| RCA vs LAD | 0.931 | 0.800 | 1.084 | 0.357 | ||
| LM vs LAD | 2.757 | 1.927 | 3.945 | < 0.001 | ||
| Number of vessels | 1.126 | 1.039 | 1.222 | 0.004 | ||
| Mean stent diameter | 0.754 | 0.658 | 0.865 | < 0.001 | ||
OR odds ratio, CI confidence interval, CKD chronic kidney disease, ACE inhibitor angiotensin-convertingenzyme inhibitor, ARB angiotensin receptor blocker, Hb hemoglobin, HDL cholesterol high density lipoprotein cholesterol, TIMI thrombolysis in myocardial infarction, LVEF left ventricular ejection fraction.
Multivariable logistic regression analyses were carried out to identify independent predictors for overall mortality and on the basis of the variables that were significant (P < 0.05) according to univariable logistic regression analysis.